174 related articles for article (PubMed ID: 17100767)
1. An adaptation of recombinant vaccinia-based ELISPOT and intracellular cytokine staining for a comparative measurement of cellular immune responses in HIV-1 and HIV-2 infections in West Africa.
Eshofonie A; van der Loeff MS; Whittle H; Jaye A
Clin Exp Immunol; 2006 Dec; 146(3):471-8. PubMed ID: 17100767
[TBL] [Abstract][Full Text] [Related]
2. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals.
Larsson M; Jin X; Ramratnam B; Ogg GS; Engelmayer J; Demoitie MA; McMichael AJ; Cox WI; Steinman RM; Nixon D; Bhardwaj N
AIDS; 1999 May; 13(7):767-77. PubMed ID: 10357375
[TBL] [Abstract][Full Text] [Related]
3. A vaccinia-based elispot assay for detection of CD8+ T cells from HIV-1 infected children.
Buseyne F; Catteau A; Scott-Algara D; Corre B; Porrot F; Rouzioux C; Blanche S; Rivière Y
J Immunol Methods; 2005 Mar; 298(1-2):105-18. PubMed ID: 15847801
[TBL] [Abstract][Full Text] [Related]
4. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
[TBL] [Abstract][Full Text] [Related]
5. Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy.
Keane NM; Price P; Stone SF; John M; Murray RJ; French MA
AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1991-6. PubMed ID: 11153082
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced disease.
Clark SA; Martin SL; Pozniak A; Steel A; Ward B; Dunning J; Henderson DC; Nelson M; Gazzard B; Kelleher P
Clin Exp Immunol; 2007 Nov; 150(2):238-44. PubMed ID: 17672869
[TBL] [Abstract][Full Text] [Related]
7. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS
J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus.
Smith JG; Liu X; Kaufhold RM; Clair J; Caulfield MJ
Clin Diagn Lab Immunol; 2001 Sep; 8(5):871-9. PubMed ID: 11527795
[TBL] [Abstract][Full Text] [Related]
9. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
Gillespie GM; Pinheiro S; Sayeid-Al-Jamee M; Alabi A; Kaye S; Sabally S; Sarge-Njie R; Njai H; Joof K; Jaye A; Whittle H; Rowland-Jones S; Dorrell L
Eur J Immunol; 2005 May; 35(5):1445-53. PubMed ID: 15832290
[TBL] [Abstract][Full Text] [Related]
10. [Immunodominance in CD8+ T cell responses to HIV-1 synthesized epitopes].
Tang YB; Tang XP; Jin X
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Sep; 21(3):217-9. PubMed ID: 17971925
[TBL] [Abstract][Full Text] [Related]
11. No differences in cellular immune responses between asymptomatic HIV type 1- and type 2-infected Gambian patients.
Jaye A; Sarge-Njie R; Schim van der Loeff M; Todd J; Alabi A; Sabally S; Corrah T; Whittle H
J Infect Dis; 2004 Feb; 189(3):498-505. PubMed ID: 14745708
[TBL] [Abstract][Full Text] [Related]
12. MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays.
Kutscher S; Allgayer S; Dembek CJ; Bogner JR; Protzer U; Goebel FD; Erfle V; Cosma A
Gene Ther; 2010 Nov; 17(11):1372-83. PubMed ID: 20535218
[TBL] [Abstract][Full Text] [Related]
13. HIV type 1-specific inter- and intrasubtype cellular immune responses in HIV type 1-infected Ugandans.
Rutebemberwa A; Auma B; Gilmour J; Jones G; Yirrell D; Rowland S; Imami N; Watera C; Kaleebu P; Whitworth J; Gotch F
AIDS Res Hum Retroviruses; 2004 Jul; 20(7):763-71. PubMed ID: 15307923
[TBL] [Abstract][Full Text] [Related]
14. Characterization of HIV-1 Gag-specific T cell responses in chronically infected Indian population.
Kaushik S; Vajpayee M; Wig N; Seth P
Clin Exp Immunol; 2005 Nov; 142(2):388-97. PubMed ID: 16232229
[TBL] [Abstract][Full Text] [Related]
15. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
[TBL] [Abstract][Full Text] [Related]
16. Comparison of HIV-specific CD8 T-cell responses among uninfected individuals exposed to HIV parenterally and mucosally.
Makedonas G; Bruneau J; Alary M; Tsoukas CM; Lowndes CM; Lamothe F; Bernard NF
AIDS; 2005 Feb; 19(3):251-9. PubMed ID: 15718835
[TBL] [Abstract][Full Text] [Related]
17. CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection.
Alatrakchi N; Graham CS; He Q; Sherman KE; Koziel MJ
J Infect Dis; 2005 Mar; 191(5):702-9. PubMed ID: 15688283
[TBL] [Abstract][Full Text] [Related]
18. A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity.
Someya K; Xin KQ; Matsuo K; Okuda K; Yamamoto N; Honda M
J Virol; 2004 Sep; 78(18):9842-53. PubMed ID: 15331719
[TBL] [Abstract][Full Text] [Related]
19. Comparison of human immunodeficiency virus (HIV)-specific T-cell responses in HIV-1- and HIV-2-infected individuals in Senegal.
Zheng NN; Kiviat NB; Sow PS; Hawes SE; Wilson A; Diallo-Agne H; Critchlow CW; Gottlieb GS; Musey L; McElrath MJ
J Virol; 2004 Dec; 78(24):13934-42. PubMed ID: 15564501
[TBL] [Abstract][Full Text] [Related]
20. Functional T cell subsets contribute differentially to HIV peptide-specific responses within infected individuals: correlation of these functional T cell subsets with markers of disease progression.
Peretz Y; Ndongala ML; Boulet S; Boulassel MR; Rouleau D; Côté P; Longpré D; Routy JP; Falutz J; Tremblay C; Tsoukas CM; Sékaly RP; Bernard NF
Clin Immunol; 2007 Jul; 124(1):57-68. PubMed ID: 17521962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
